Resume
Raymond Singer, Ph.D.
For an updated vita, click on the link showed above. The vita below is a sample vita, presented here for your convenience.
Dr. Raymond Singer, Ph.D., a neuropsychologist, certified by the American Board of Professional Neuropsychology - with Added Forensic Qualifications - and a neurobehavioral toxicologist (neurotoxicologist), specializes in research, evaluation and consultation regarding the effects of toxic substances on neurobehavioral function. His research has been presented in numerous venues, including publications, presentations, and courses at professional seminars. He has testified as an expert witness in civil and criminal cases in numerous state and federal courts.
| Degree | Institution | Year | Department |
| Doctor of Philosophy | Washington State University | 1978 | Psychology |
| Master of Science | Washington State University | 1975 | Psychology |
| Bachelor of Arts | University of Rochester | 1972 | Psychology |
POST-DOCTORAL EDUCATION IN ENVIRONMENTAL EPIDEMIOLOGY AND
EFFECTS OF TOXIC SUBSTANCES ON THE NERVOUS SYSTEM
1981 - 1982 Fellow, Mount Sinai School of Medicine, Department of Community Medicine, Environmental Sciences Laboratory, New York City
1979 - 1981 National Institute of Health Post-Doctoral Fellow in Environmental Epidemiology, Mount Sinai School of Medicine, New York City
POST-DOCTORAL EDUCATION IN BIOLOGICAL PSYCHIATRY
1978 - 1979 National Institute of Health Post-Doctoral Fellow in Biological Psychiatry, Millhauser Laboratory, New York University Medical Center, New York City
ADDITIONAL NATIONAL INSTITUTES OF HEALTH AWARDS
1972 - 1976 National Institute of Health, National Research Service Award, researched visual function, served as a teaching assistant in Sensory Psychology
Diplomate in Neuropsychology with Added Qualification in Forensic Neuropsychology, American Board of Professional Neuropsychology
Psychology licenses, New Mexico and New York
Fellow status
Fellow, National Academy of Neuropsychology. Designated for “significant contributions to the Science and Profession of Neuropsychology”, June 30, 2004.
Fellow, American Psychological Association. Elected in recognition of “outstanding, substantial and unusual contribution to psychology” in Divisions of General Psychology and Psychologists in Independent Practice.
Fellow, Association for Psychological Society (Formerly the American Psychological Society). Permanently designated in 1992 for “Distinguished Contributions to Psychological Science”.
Notable professional contributions
Selected for Forensic Grand Rounds, Forensic Evaluation of a Mold (Repeated Water Intrusions) Neurotoxicity Case. National Academy of Neuropsychology, 25th Annual Meeting, Tampa, Florida, October 22, 2005.
Selected for Adult Grand Rounds, Neurotoxicity evaluation of a new commercial solvent.
National Academy of Neuropsychology, 21st Annual Meeting, San Francisco, California, October 31, 2001.
American Academy of Clinical Toxicology
American Industrial Hygiene Association (Former member)
American Psychological Association
International Neurotoxicology Association
(One the earliest members; app. 250 members in 2006)
National Academy of Neuropsychology
(Member #102, since 1989; over 3,000 members in 2004)
Roundtable of Toxicology Consultants, Society of Toxicology
(Vice-President, 1994; President, 1995-96; Treasurer, 1997-99)
Society of Toxicology (Full Member)
2008; 2005-2001 Consultant, The Defender Association, Washington State public defense work
2008 Manuscript review, Archives of Applied Neuropsychology
2008 Consultant, Norfolk Southern Railway Company
2007 Book chapter review, American Industrial Hygiene Association, Toxicology Principles for the Industrial Hygienist, Chapter 7A: Toxicology of Sensory Organs.
2007 Manuscript review, Environmental Health Perspectives, scientific journal published by the USA National Institute of Environmental Health Sciences. Paper concerned with problems in brain structure and function caused by a toxic chemical environmental pollutant.
2007 Consultant, Paul Revere Insurance Company
2007-2005 Federal Public Defender’s Office, Arizona and New Mexico
2006 Consultant, Prudential Financial, administered by Psybar, Inc., a national professional services company offering psychological and psychiatric consultations and evaluations for insurance companies and other organizations
2006-2003 Consultant, New Mexico Department of Health (via Mentor New Mexico, High Desert Family Services and other agencies), providing services for brain injury clients (Traumatic, toxic, etc.)
2002-2000 Consultant, Missouri State Public Defender Department
2001- Consultant, UNUM Insurance Company (several cases since 2001, not every year)
2001-2000 Consultant, New York State Worker’s Compensation Board
2001-1998 Consultant, New Mexico State Department of Vocational Rehabilitation
2001-1991 Consultant, New Mexico Public Defender Department.
2001- 1983 Adjunct Instructor, Mount Sinai School of Medicine, Department of Community Medicine, New York City
2000 Consultant, U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, through Eastern Research Group, Lexington, Mass.: Toxicology profiles and medical management guidelines regarding toluene, chlordane, formaldehyde, and gasoline (4 separate projects).
2000-1999 Consultant, United States District Court, New Mexico
2000-1994 Medical Education Committee, St. Vincent's Hospital, Santa Fe
2000 -1993 Medical Staff Associate, St. Vincent's Hospital, Santa Fe
1994-1993 Instructor, Santa Fe Community College (Course in hazardous materials)
1994-91 Consultant in neuropsychology and neurotoxicology, United States Department of Justice, Environmental Crimes Section, and Federal Bureau of Investigation
1991-90 Consultant Neuropsychologist, University of the State of New York, Office of Vocational Services
1991-90 Consultant Psychologist, Pius XII Youth and Family Services, Chester, NY
1991-90 Consultant Psychologist, Sugarloaf Union School District, Chester, NY
1991-90 Consultant Psychologist, New Hope Guild, Brooklyn, NY
1991-89 Consultant, New York State Public Defender Department (years are approximate).
1991-83 Consultant Psychologist, New York State Department of Social Services, Office of Disability Determinations
1984-83 Consultant in Psychology, 99th Street Rego Park Medical Arts
1983- Expert witness in toxic chemical litigation
1983- Independent practice: Neuropsychology, specializing in effects of toxic substances on the nervous system (neurotoxicology, neurobehavioral toxicology, psychology, environmental health)
1979-79 Clinical Psychology Intern, Park East Psychological Associates, New York City
1978-72 Teaching and Research Assistant, Department of Psychology, Washington State University, Pullman, Washington
ADDITIONAL PROFESSIONAL TRAINING
Toastmasters International Communication and Leadership Program, Competent Toastmaster Certificate, June 30, 2004.
Who's Who in the World (13th-16th Edition; app. 37,000 - 40,000 biographies)
Who's Who in Science and Engineering (2nd - 3rd Edition)
Who's Who in the East (22nd Edition)
Who's Who of Emerging Leaders in America (3rd Edition)
Singer, R. (1990). Neurotoxicity Guidebook. New York: Van Nostrand Reinhold. Revised First Edition, Aventine Press, 2005.
BOOK CHAPTERS OR CONTRIBUTIONS
1. Singer, R. (2007). Neuropsychological assessment of toxic exposures. In The Neuropsychology Handbook: Third Edition, Vol 2. New York: Springer.
2. Singer, R. (2005). Clinical evaluation of suspected mold neurotoxicity. Proceedings of the Fifth International Conference on Bioaerosols, Fungi, Bacteria, Mycotoxins and Human Health, Albany, New York: Boyd Printing.
3. Singer, R. (2003). Forensic neurotoxicology. In the Handbook of Forensic Neuropsychology. New York: Springer.
4. Singer, R. (1997). Neuropsychological assessment of toxic exposures. In The Neuropsych-ology Handbook: Second Edition, Vol 2. New York: Springer.
5. Singer, R. (1994). Neurotoxicity evaluation. In Principles and Practice of Forensic Psychiatry, edited by Richard Rosner. New York: Van Nostrand Reinhold.
6. Singer, R. (1992). Agricultural and domestic neurotoxic substances. In Preventable Brain Damage: Brain Vulnerability and Brain Health, edited by W. Gary Cannon, Lawrence Hartlage, and Donald L. Templer. New York: Springer Publishing Company.
7. Singer, R. (1991). Nervous system monitoring for early signs of chemical toxicity. Chapter in Biological Monitoring of Exposure to Chemicals: Metals, edited by H. Kenneth Dillon and M. Ho. New York: John Wiley & Sons.
8. Singer, R. (1987). How to prove nervous system dysfunction. A Guide to Toxic Torts. New York: Matthew Bender.
9. Letz, R. & Singer, R. (1985). Neuropsychological tests. In P. Grandjean (Ed.), Neurobehavioral Behavioral Methods in Occupational and Environmental Health (Document 6, pp. 17 -- 18). Copenhagen: World Health Organization.
1. Singer, R. (2002). Book review: The Forensic Pharmacology of Drugs of Abuse. International Journal of Toxicology, 21:381-382.
2. Singer, R. (1988). Early recognition of toxicity by assessing nervous system function. Biomedical and Environmental Sciences, 1, 365-362.
3. Singer, R. (1988). Methodology of forensic neurotoxicity evaluation: PCB case. Toxicology, 49, 403-408.
4. Singer, R., Valciukas, J., & Rosenman, K. D. (1987). Peripheral neurotoxicity in workers exposed to inorganic mercury compounds. Archives of Environmental Health, 42(4), 181-184.
5. Singer, R. & Scott, N. E. (1987). Progression of neuropsychological deficits following toluene diisocyanate exposure. Archives of Clinical Neuropsychology, 2(2), 135-144.
6. Valciukas, J., Lilis, R., Singer, R., Glickman, L., & Nicholson, W. J. (1985). Neurobehavioral changes among shipyard painters exposed to solvents. Archives of Environmental Health, 40(1), 47-52.
7. Singer, R., Valciukas, J., & Lilis, R. (1983). Lead exposure and nerve conduction velocity: The differential time course of sensory and motor nerve effects. Neurotoxicology, 4(2), 193-202.
8. Singer, R., Moses, M., Valciukas, J., Lilis, R., & Selikoff, I. J. (1982). Nerve conduction velocity studies of workers employed in the manufacture of phenoxy herbicides. Environmental Research, 29, 297-311.
9. Valciukas, J. & Singer, R. (1982). The embedded figures test in epidemiological studies of environmental neurotoxic agents. Environmental Research, 28, 183-198.
10. Valciukas, J., Lilis, R., Singer, R., Fischbein, A., Anderson, H. A., & Glickman, L. (1980). Lead exposure and behavioral changes: Comparisons of four occupational groups with different levels of lead absorption. American Journal of Industrial Medicine, 1, 421-426.
11. Young, F., Singer, R., & Foster, D. (1975). The psychological differentiation of male myopes and non-myopes. American Journal of Optometry, 52 (10), 679-686.
1. Singer, R. and Johnson, D. D. (2006, March). Recognizing neurotoxicity, TRIAL, Mar. 2006, Volume 42, Number 3.
2. Singer, R. (1994, Spring). Medical neuropsychology: An aid to diagnosis and treatment. Physician's Forum, St. Vincent's Hospital.
3. Singer, R. (1990, May). Toxic chemical effects on the human nervous system. The Expert Witness Journal, 2, 5:1-20.
4. Singer, R. (1990, March). Neuropsychological toxicology: Identification and assessment of human neurotoxic syndromes. Bulletin, National Academy of Neuropsychologists, 7, 1:6-7.
5. Singer, R. (1989, January). How I learned to stop worrying and love the cross-examination. The Expert Witness Journal, 1(1), 9. Reprinted in the Journal of the Southwest Association of Forensic Examiners (1989) 8:3.
6. Singer, R. (1988, Summer). Neuropsychology and Toxicology: Interface. Newsletter, Rockland County Psychological Society
7. Singer, R. (1988, Winter). Letter on chemist suicides. CHASNotes, American Chemical Society, 4(1), p. 5.
8. Singer, R. (1987, March). Nervous system: Early detection for chemical hazards. Professional Safety, pp. 37-41. Reprinted by East Tennessee State University for ENVH 5700, 1992.
9. Singer, R. (1985, November). Proving damages in toxic torts: Nervous system dysfunction. TRIAL, Vol. 21, 11, pp. 59-60.
Singer, R. (1985, August). Neuropsychological evaluation of neurotoxicity. In Neurobehavioural Methods in Occupational and Environmental Health: Document 3. Environmental Health pp. 86-90. Second International Symposium, Copenhagen, Denmark: World Health Organization Regional Office for Europe.
1. Singer, R. (2008). Forensic evaluation of neuropsychological decline following solvent exposure. Archives of Clinical Neuropsychology, Volume 23:6, 746.
2. Singer, R. and Gray, M. (2007). Neuropsychological evaluation of a practicing physician with mold exposure. Archives of Clinical Neuropsychology, Volume 22, Issue 7, September, p 892.
3. Singer, R. (2006). Forensic neuropsychological autopsy of a suicide following occupational solvent exposure. Archives of Clinical Neuropsychology, Volume 21, Issue 6, p. 606.
4. Singer, R. (2005). Forensic evaluation of a mold (repeated water intrusions) neurotoxicity case. Archives of Clinical Neuropsychology, Volume 20, Issue 7, p. 808.
5. Singer, R. (2003). Neurobehavioral evaluation of household exposure to Dursban. Toxicological Sciences, Vol. 72, Number S-1, March, p. 311.
6. Singer, R (2002). Panic disorder can be caused by neurotoxicity. Archives of Clinical Neuropsychology, Volume 17, Issue 8, pp. 813-814.
7. Singer, R. (2002). Neurobehavioral evaluation of residual effects of low-level bystander organophosphate pesticide exposure. Fundamental and Applied Toxicology, Supplement: The Toxicologist, Vol. 55, Number 1, March.
8. Singer, R. (2001). Neurotoxicity evaluation of a new solvent. Archives of Clinical Neuropsychology, 16 (2001), 697.
9. Singer, R. (2000). Neurobehavioral evaluation of residual effects of acute chlorine ingestion. Fundamental and Applied Toxicology, Supplement: The Toxicologist, Vol. 54, Number 1, p. 181, March.
10. Singer, R. (1999). Neurobehavioral screening of child and adult bystander exposure to toluene diisocyanate application. Fundamental and Applied Toxicology, Supplement: The Toxicologist, 48, 1-S, March, p. 359.
11. Singer, R. (1999). Neuropsychological evaluation of bystander exposure to pesticides. Journal of Neuropsychiatry and Clinical Neurosciences. Vol 11, #1, Winter, pp. 161-162.
12. Singer, R. (1999). Neurotoxicity from municipal sewage sludge. Archives of Clinical Neuropsychology, 14, 160.
13. Singer, R. (1998, January). Evaluating a carbonless copy paper neurotoxicity case. Archives of Clinical Neuropsychology. Volume 13, Number 1, p. 127.
14. Singer, R. (1997, March). Sick building syndrome: Neuropsychological study. Fundamental and Applied Toxicology, Supplement: The Toxicologist, 36,1:59, Part 2.
15. Singer, R. (1997). Neuropsychological evaluation of desipramine toxicity. The Journal of Neuropsychiatry and Clinical Neurosciences, 9, 1, 1997, p. 167.
16. Singer, R. (1997). Wood-preserving chemicals, multiple sclerosis, and neuropsychological function. Archives of Clinical Neuropsychology, 12, 4, p. 404.
17. Singer, R. (1996, March). Neurotoxicity from outdoor, consumer exposure to a methylene chloride product. Fundamental and Applied Toxicology, Supplement: The Toxicologist, 30, 1, Part 2.
18. Singer, R. (1996). Neurobehavioral screening of breast implant women. Archives of Clinical Neuropsychology, 11, 5.
19. Singer, R. (1995). Neuropsychological assessment of a practicing dentist with elevated urinary mercury. Fundamental and Applied Toxicology, Supplement: The Toxicologist, 15, 1, March, 1995.
20. Singer, R. (1994). Chronic polychlorinated biphenyl exposure and neurobehavioral effects. The Toxicologist, 14, 1, March, 1994.
21. Singer, R. (1990). Formaldehyde neurotoxicity. Archives of Clinical Neuropsychology, 5:2, 214.
22. Singer, R. (1990). Neurotoxicity can produce "MS-like" symptoms. Journal of Clinical and Experimental Neuropsychology, 12:1, 68.
23. Singer, R. (1989, March). Methodology of forensic neurotoxicity evaluation: PCB case. Toxicology Abstracts, 12(3).
24. Singer, R (1987, April). Forensic evaluation of chlordane neurotoxicity. Proceedings of the First Meeting of the International Neurotoxicology Association. Lunteren, The Netherlands, May 10-16, 1987. Proceedings. Part 1. Toxicology. 1988 Apr;49(1):1-201.
25. Singer, R (1987, April). Polychlorinated biphenyl transformer fluid neurotoxicity: Case study. Proceedings of the First Meeting of the International Neurotoxicology Association. Lunteren, The Netherlands, May 10-16, 1987. Proceedings. Part 1. Toxicology. 1988 Apr;49(1):1-201.
26. Singer, R. & Scott, N. E. (1987). Computerized screening for human neurotoxicity by questionnaire: Preliminary results of the neurotoxicity screening survey. Journal of the American College of Toxicology, 6(6).
27. Singer, R. & Scott, N. E. (1987). Progression of neuropsychological deficits following toluene diisocyanate exposure. Journal of Clinical and Experimental Neuropsychology, 9(1).
28. Singer, R. & Scott, N. E. (1987). Neuropsychological evaluation of cyclodiene insecticide toxicity. The Toxicologist, 7 (1), 248.
29. Singer, R. (1986). Future directions of toxicology: A neurotoxicologist's point of view. Journal of the American College of Toxicology, 5 (6), 603.
30. Singer, R. (1986). Managing risk of occupational toxicity. Journal of the American College of Toxicology, 5(6), 603.
31. Singer, R. (1986). Prevention of neurotoxicity at the workplace. The Toxicologist, 6(1), 283.
32. Singer, R. (1985). A model neurotoxicity prevention program for biological monitoring of workers at risk. Journal of the American College of Toxicology, 4(6), 348.
33. Singer, R., Valciukas, J., & Lilis, R. (1982). Nerve conduction velocity studies of low-level lead exposure compared with low-level lead and arsenic exposure. Neurotoxicology, 3(3).
1. Singer, R. (2003). Natural Land Restoration: Mining Sites. Presented at a special meeting of New Mexico State Bureau of Mines & Mineral Resources managers, April 2nd, Santa Fe.
2.Singer, R. (2003). Natural Land Restoration: Hazardous Waste Sites. Presented at a special meeting of USA Environmental Protection Agency Region 6 managers, April 9th, Dallas.
3.Singer, R. (2002, April). Death Penalty Mitigation Factors: Neurotoxicity. 18th Annual Symposium of the American College of Forensic Psychology, April 21st, San Francisco.
4. Singer, R. (2001, November). Neurotoxicity evaluation of a new solvent. Grand Rounds, 21st Annual Meeting of the National Academy of Neuropsychology, San Francisco, November 2nd.
5. Singer, R. (2001, August). Multiple chemical sensitivity and neurotoxicity. 2001 Multiple Chemical Sensitivity Conference, sponsored by the Chemical Injury Information Network, August 14th, 2001, Santa Fe, New Mexico.
6. Singer, R. (2001, April). Disability claims involving workers exposed to neurotoxic substances. 17th Annual Symposium of the American College of Forensic Psychology, April 26, Toronto.
7. Singer, R. (2000, April). Forensic assessment of neurobehavioral disorders following atypical chemical exposures. 16th Annual Symposium of the American College of Forensic Psychology, April 6, Newport Beach.
8. Singer, R. (2000, January). Identifying neurotoxicity in clinical practice. University of New Mexico School of Medicine, Department of Psychiatry, Albuquerque, Jan. 21st.
9. Singer, R. (1999, November). Evaluation of neurobehavioral toxicity disorders. University of New Mexico School of Medicine, Neuroscience Department, Albuquerque, Nov. 18th.
10. Singer, R. (1999, October). An overview: Clinical diagnosis of chemically caused neurobehavioral toxicity. American Academy of Environmental Medicine 34th Annual Meeting, Coeur d’Alene, October 8th , 1999.
11. Singer, R. (1999, October). Clinical diagnosis of neurobehavioral toxicity. Washington State University, Department of Psychology Colloquium, Pullman, October 12th, 1999.
12. Singer, R. (1999, June). The neurotoxicity of everyday chemicals. Funded by, and upon invitation of, Kassenarztliche Vereinigung (the regional association of government, doctors and insurance payers), Nord-Wurttemberg, Stuttgart, Germany, June 10th .
13. Singer, R. (1999, June). Neuropsychometric approaches to diagnosing brain damage from toxic substances. Funded by, and upon invitation of, Kassenarztliche Vereinigung, Nord-Wurttemberg, Stuttgart, Germany, June 10th.
14. Singer, R. (1997, May). Neuropsychological testing methods: Malingering and neurotoxic injury. Maricopa County Bar Association, Continuing Legal Education, May 8, Phoenix.
15. Singer, R. (1997, February). Forensic applications of neuropsychology and neurotoxicology. First District of the New Mexico Judicial Bar Association, Monthly Meeting, February 17, Santa Fe.
16. Singer, R. (1993, November). Introduction to applied neurotoxicology. Health Conference on Multiple Chemical Sensitivity, Washington Committee on Occupational Safety and Health, Seattle.
17. Singer, R. (1993, November). The clinical picture of environmental and occupational neurotoxicity. All Hospital Medical Education Lecture, St. Vincent's Hospital, Santa Fe, New Mexico.
18. Singer, R. (1993, November). Living with brain damage: Neuropsychological effects of head trauma. New Mexico Trial Lawyers' Association, Albuquerque, New Mexico.
19. Singer, R. (1986, July). Elements of causation in toxic torts. Address to the Association of Trial Lawyers of America Annual Convention, New York.
20. Singer, R. (1986, March). Proof of pesticide toxicity. Address to the Fourth National Pesticide Forum, Washington.
21. Singer, R. (1984, July). Evaluation of neurotoxicity in toxic chemical litigation. Address to the Association of Trial Lawyers of America Annual Convention, Seattle.
22. Singer, R. (1980, May). The neuropsychological evaluation of patients affected by occupational neurotoxic agents. Address to the New York State Psychological Association Convention, New York.
23. Singer, R. (1976, February). Can myopia be prevented? Address to the Washington State University chapter of Sigma XI.
SCIENTIFIC PAPERS AND PRESENTATIONS
1. Singer, R. (2008). Forensic evaluation of neuropsychological decline following solvent exposure. National Academy of Neuropsychology 28th Annual Meeting, New York City, October 25, 2008.
2. Singer, R. and Gray, M. (2007). Neuropsychological evaluation of a practicing physician with mold exposure. National Academy of Neuropsychology, 27th Annual Meeting, Scottsdale, Arizona, November 17.
3. Singer, R. (2007, June). Forensic evaluation of a mercury and lead case. 11th Annual Meeting of the International Neurotoxicology Association, Monterey, California, USA.
4. Singer, R. (2006). Forensic neuropsychological autopsy of a suicide following occupational solvent exposure. National Academy of Neuropsychology, 26th Annual Meeting, San Antonio, October 28.
5. Singer (2005). Forensic evaluation of a mold (repeated water intrusions) neurotoxicity case. Forensic Grand Rounds, National Academy of Neuropsychology, 25th Annual Meeting, Tampa, October 22.
6. Singer, R. (2003, September). Clinical evaluation of suspected mold neurotoxicity. Fifth International Conference on Bioaerosols, Fungi, Bacteria, Mycotoxins and Human Health, Saratoga Springs, New York, September 10.
7. Singer, R. (2003, June). Forensic evaluation of solvent neurotoxicity: Cognitive and affective disorder. 9th Meeting of the International Neurotoxicology Association, Dresden, Germany.
8. Singer, R. (2003). Neurobehavioral evaluation of household exposure to Dursban. 42nd Annual Meeting of the Society of Toxicology, March 12, 2003, at the Salt Palace Convention Center, Salt Lake City, Utah.
9. Singer, R (2002). Panic disorder can be caused by neurotoxicity. 22nd Annual Meeting of the National Academy of Neuropsychology, Miami, Florida, October 12.
10. Singer, R. (2002). Neurobehavioral evaluation of residual effects of low-level bystander organophosphate pesticide exposure. 41nd Annual Meeting of the Society of Toxicology, Nashville, March 20.
11. Singer, R (2001). Neurotoxicity evaluation of a new commercial solvent. Adult Grand Rounds at the 21st Annual Meeting of the National Academy of Neuropsychology, San Francisco, California, October 31.
12. Singer, R. (1999). Neurotoxizitat alltagsublicher chemischer Substanzen. Text of address to a section of the German Parliament. Umweltbelastungen und Gesundheit, 9. Juni 1999, SPD Bundestagfraktion, Platz der Rupublik 11011 Berlin.
13. Singer, R. (1999). Neurobehavioral screening of child and adult bystander exposure to toluene diisocyanate application. 39th Annual Meeting of the Society of Toxicology, New Orleans, March 17.
14. Singer, R. (1999). Neuropsychological evaluation of bystander exposure to pesticides . 10th Annual Meeting of the American Neuropsychiatry Association, New Orleans, Feb. 2.
15. Singer, R. (1998). Neurotoxicity from municipal sewage sludge. 18th Annual Meeting of the National Academy of Neuropsychology, Washington, D.C., November 6.
16. Singer, R. (1997). Evaluating a carbonless copy paper neurotoxicity case. 17th Annual Meeting of the National Academy of Neuropsychology, Las Vegas, November 12.
17. Singer, R. (1997). Sick building syndrome: Neuropsychological study. 36th Annual Meeting of the Society of Toxicology, Cincinnati, March 10.
18. Singer, R. (1997). Neuropsychological evaluation of desipramine toxicity. 8th Annual Meeting of the American Neuropsychiatry Association, Orlando, Feb. 4.
19. Singer, R. (1996). Wood-preserving chemicals, multiple sclerosis, and neuropsychological function. 16th Annual Meeting of the National Academy of Neuropsychology, New Orleans, October 31.
20. Singer, R. (1996, March). Neurotoxicity from outdoor, consumer exposure to a methylene chloride product. Society of Toxicology Annual Meeting, Anaheim, March 11.
21. Singer, R. (1995, November). Neurobehavioral screening of breast implant women. Annual Meeting of the National Academy of Neuropsychology, San Francisco, November 3.
22. Singer, R. (August, 1995). Symposium: Forensic neuropsychology: Detecting malingering and coping with cross-examination. Annual Meeting of the American Psychological Association, New York.
23. Singer, R. (March, 1995). Neuropsychological assessment of a practicing dentist with elevated urinary mercury. 34th Annual Meeting of the Society of Toxicology, Baltimore.
24. Singer, R. (August, 1994). Neuropsychological toxicology in private practice. Presented to Division 42, Annual Meeting of the American Psychological Association, Los Angeles.
25. Singer, R. (March, 1994). Chronic polychlorinated biphenyl exposure and neurobehavioral effects. 33rd Annual Meeting of the Society of Toxicology, Dallas.
26. Singer, R. (April, 1993). Forensic neuropsychological toxicology. Ninth Annual Symposium of Forensic Psychology, Santa Fe.
27. Singer, R. (October, 1990). Risk factors for Alzheimer's disease. American Public Health Association's 1990 Annual Meeting, New York.
28. Singer, R. (1990, February). Neurotoxicity can produce "MS-like" symptoms. 18th Annual Meeting of the International Neuropsychological Society, Orlando, February 16.
29. Singer, R. (1989, November). Formaldehyde neurotoxicity. 9th Annual Meeting of the National Academy of Neuropsychologists, Washington, November 2.
30. Singer, R. (1988, December). Neurotoxicity or Nothing?: Deficit Measurement and Malingering. 3rd International Symposium on Neurobehavioral Methods in Occupational and Environmental Health, World Health Organization, Washington DC.
31. Singer, R. & Scott, N. E. (1987, December). Computerized screening for human neurotoxicity by questionnaire: Preliminary results of the neurotoxicity screening survey. 8th Annual Meeting of the American College of Toxicology, Baltimore.
32. Singer, R. (1987, May). Forensic evaluation of chlordane neurotoxicity. 1st Meeting of the International Neurotoxicology Association, Lunteren, The Netherlands.
33. Singer, R. (1987, May). Polychlorinated biphenyl transformer fluid neurotoxicity: Case study. 1st Meeting of the International Neurotoxicology Association, Lunteren, The Netherlands.
34. Singer, R. & Scott, N. E. (1987, February). Neuropsychological evaluation of cyclodiene insecticide toxicity. 26th Annual Meeting of the Society of Toxicology, Washington.
35. Singer, R. & Scott, N. E. (1987, February). Progression of neuropsychological deficits following toluene diisocyanate exposure. 15th International Neuropsychological Society Meeting, Washington.
36. Singer, R. (1986, November). Early recognition of toxicity by assessing nervous system function. Annual Meeting of the Society of Ecotoxicology and Environmental Safety, Rome, Italy.
37. Singer, R. (1986, November). Future directions of toxicology: A neuropsychologist's point of view. 7th Annual Meeting of the American College of Toxicology, Philadelphia.
38. Singer, R. (1986, November). Managing risk of occupational toxicity. Seventh Annual Meeting of the American College of Toxicology, Philadelphia.
39. Singer, R. (1986, March). Prevention of neurotoxicity at the workplace. 25th Annual Meeting of the Society of Toxicology, New Orleans.
40. Singer, R. (1985, November). A model neurotoxicity prevention program for biological monitoring of workers at risk. 6th Annual Meeting of the American College of Toxicology, Washington.
41. Singer, R. (1985, September). Psychosis: Schizophrenia or chemical waste exposure. At Biological aspects of schizophrenia, a symposium conducted at IV World Congress of Biological Psychiatry, Philadelphia.
42. Singer R. (1985, August). Neuropsychological evaluation of neurotoxicity. 2nd International Symposium on Neurobehavioral Methods in Occupational and Environmental Health, World Health Organization, Copenhagen, Denmark.
43. Singer, R. (1985, April). Nervous system monitoring for early signs of chemical toxicity. 189th American Chemical Society National Meeting, Miami.
44. Singer, R. (1984, February). Peripheral nervous system assessment in the evaluation of toxic chemical exposure. 12th Annual Meeting of the International Neuropsychological Society, Houston.
45. Singer, R. (1983, December). Neural indicators of phenoxy herbicide exposure. Annual Meeting of the Society for Occupational and Environmental Health, Washington.
46. Singer, R., Valciukas, J., & Lilis, R. (1982, September). Nerve conduction velocity studies of low-level lead exposure compared with low-level lead and arsenic exposure. International Conference on Neurotoxicology of Selected Chemicals, Chicago.
47. Singer, R., Valciukas, J., & Lilis, R. (1981, September). Lead exposure and nerve conduction velocity: The differential time course of sensory and motor nerve effects. XI Triennial World Congress of Pathology, Jerusalem, Israel.
48. Singer, R., Moses, M. Valciukas, J., Lilis, R. & Selikoff, I. J. (1981, September). Nerve conduction velocity studies of workers employed in the manufacture of phenoxy herbicides. XX International Congress of Occupational Health, Cairo, Egypt.
49. Singer, R. (1979, September). The role of the psychologist in the prevention of myopia. Annual Meeting of the American Psychological Association, New York.
50. Singer, R. (1979, September). The Camphill approach to the education of the retarded person. Symposium at Annual Meeting of the American Psychological Association, New York.
51. Singer, R. and Gelberman, J. (1979, September). Two contributions of Jewish mysticism to psychotherapy. Annual Meeting of the American Psychological Association, New York.
52. Singer, R. (1979, May). The behavioral etiology of myopia. Annual meeting of the Eastern Psychological Association, Philadelphia.
53. Singer, R., Young, F., & Rokeach, M. (1977, April). Values as predictors of visual refractive error in Barrow Eskimos. Western Psychological Association Convention, Seattle.
54. Singer, R. (1975, April). The association of personality and myopia. Western Psychological Association Convention, Sacramento.
NATIONAL INSTITUTE OF HEALTH REPORTS
1. Singer, R., Valciukas, J., & Lilis, R. (1982, November). Nerve conduction velocity studies assessment of copper smelter workers. In Health Hazards Among Copper Smelter Workers. Report to the National Institute of Environmental Health Science.
2. Lilis, R., Valciukas, J., Singer, R., Fischbein, A., Anderson, H. A., & Glickman, L. (1981, June). Assessment of lead health hazards in an auto body shop at an automobile assembly plant. Report to the National Institute of Environmental Health Sciences.
PROFESSIONAL WORKSHOPS AND COURSES PRESENTED
1. Personality and Anxiety Disorders, Such as Panic Attacks, From Neurotoxicity. 24th Annual Symposium of the American College of Forensic Psychology. April 13th, 2008, San Francisco.
2. Forensic Neuropsychology and Evaluation of Toxic Chemical Injuries. 23rd Annual Symposium of the American College of Forensic Psychology, May 3, 2007, Santa Fe.
3. Neurotoxicity of Chemical and Biological Weapons. Instructor, Fall Meeting of the Roundtable of Toxicology Consultants (a sub-group of members of the Society of Toxicology). Montreal, September 16, 2006.
4. Multiple Chemical Sensitivity Case Definition Workshop, panelist (neuropsychology, neurotoxicology). Sponsored by the Chemical Injury Information Network. San Francisco, August 4-6, 2006. Only 30 panelists were invited from all MCS researchers and clinicians worldwide.
5. Forensic Evaluation of a Mold (Repeated Water Intrusions) Neurotoxicity Case. Third Annual Mold Conference: Mold, Mycotoxins, and the Current State of Science. Hosted by Medical Center for Immune and Toxic Disorders. The Woodlands, Texas, April 1st, 2006.
6. Junk Science, Manufactured Doubt, and Disinformation versus Science in Litigation. Instructor, Summer Meeting of the Roundtable of Toxicology Consultants (a sub-group of members of the Society of Toxicology), Gaithersburg, MD, August 27th, 2005.
7. Clinical and Forensic Mold Neurotoxicity Case Report. Second Mold Conference. Hosted by Immunosciences Lab., Inc., Beverly Hills, California, October 16, 2004.
8. Forensic Evaluation of Mold Neuropsychological Toxicology. 20th Annual Symposium of the American College of Forensic Psychology, April 1-4, 2004, San Francisco.
9. Forensic Assessment of Neurotoxicology. Sole Instructor, Fall Meeting of the Roundtable of Toxicology Consultants (a sub-group of members of the Society of Toxicology), Williamsburg, Virginia, presented October 16th, 2003.
10. Forensic Evaluation of Mold Neurotoxicity. Speaker, Environmental Issues of the 21st Century. American Association of Legal Nurse Consultants, Greater Sacramento Area Chapter, October 20, 2001, Sacramento, California.
11. Facilitator, 2001 Multiple Chemical Sensitivity Conference, sponsored by the Chemical Injury Information Network, August 13-15, 2001, Santa Fe.
12. Basic Principles of Forensic Neuropsychological Toxicology. 14th Annual Symposium of the American College of Forensic Psychology, May 1, 1998, San Francisco.
13. Psychology of Brain Injury. May 28, 1994. Presented with Santa Fe Rehabilitation, Santa Fe. Topics taught: Mechanics and physiology of brain injury; neuropsychological evaluation of brain injured patients; neurotoxic brain injury: Subtle and overt effects.
14. Neurotoxicity Evaluation, Diagnosis and Prevention. American College of Toxicology 13th Annual Meeting, San Francisco, October 24, 1992.
15. Clinical Evaluation of Patients for Neurotoxicity. American Psychological Association Centennial Convention, Washington, D.C., August 18, 1992.
16. Forensic Neuropsychological Toxicology. National Academy of Neuropsychology Eleventh Annual Meeting, Dallas, November 1, 1991.
17. Forensic Neuropsychological Toxicology. National Academy of Neuropsychology Eighth Annual Meeting, Orlando, November 4, 1988.
1. Healthy People 2000: Citizens Chart the Course. Chapter of Environmental and Public Health, p. 148-149. Institute of Medicine, National Academy Press, Washington, 1990.
2. Neurotoxins - A wider threat than once thought. Safety Compliance Letter, Bureau of Business Practice, Prentice-Hall, July 25, 1988:1614.
The A to Z Guide to Toxic Foods and How to Avoid Them. Author, Lynn Sonberg, 1992, Simon and Schuster, New York.
APPEARANCES, TESTIMONY AND WORK FOR LEGISLATURES
(STATE, NATIONAL, INTERNATIONAL)
1. Singer, R. (1999, June). The neurotoxicity of everyday chemicals. Address to a section of the German Parliament. The Great Assembly Hall of Parliament (Deutscher Bundestag), Wasserwerk, Bonn, Germany, June 9th. Funded by and upon invitation of the German Federal Government, SPD Bundestagfraktion.
2. The Toxicity of Gasoline Additives (1987). Research funded by the National Renewable Fuels Association, and circulated among U.S. Congress and staff, regarding Congressional regulation of neurotoxic chemicals in gasoline.
3. Singer, R. (1988, March). Neurotoxicity reduction. Testimony to the United States Public Health Service, Regional Hearings on National Health Objectives for the Year 2000, New York, New York.
4. Singer, R. (1985, October). Neurotoxicity can be prevented. Written and submitted to hearings before the Subcommittee on Investigations and Oversight of the Committee on Science and Technology, United States House of Representatives, serial No. 99-68, "Neurotoxins at home and in the workplace."
5.. Singer, R. (1985, September). Prevention of neurotoxicity. Testimony presented to the United States Food and Drug Administration Symposium on Predicting Neurotoxicity from Preclinical Data.
6. Singer, R. (1984, September). Are pesticides safe? Testimony presented to the New Jersey State Senate.
ARTICLES, RADIO AND APPEARANCES FOR THE GENERAL PUBLIC
1. Interview, Psychiatric Drugs and Violence: The Virginia Tech Shooter. The Gary Null Show, New York City, April 20, 2007.
2. Interview, Aspartame Neurotoxicity, Jeff Rense Program, GlobalStar Communications, Telstar 5 (Intelsat Americas 5 ) KU Band, Internet radio, 9-10 pm MT, February 19, 2007.
3. Interview, Aspartame Neurotoxicity, KUNM Radio - 89.9 FM, Albuquerque, February 12, 2007.
4. Interview, "Environmental Health Hour" with Dr. Albert Robbins, WWNN Radio-1470 AM
January 28th, 2007.
5. Interview segment, Friendly Fire (2006), Gary Null Productions, New York City, Gulf War Syndrome journalistic documentary.
6. Interview, Canadian Broadcasting Corporation, Wild Rose Forum, Host and producer, Don Hill. Subject: Human Health Effects of Pesticides, January 21, 2003.
7. Interview, Canadian Broadcasting Corporation, Radio One, Nightwatch, Host Don Hill, Talk Radio: Subject: Neurotoxic Chemicals in the Environment, August 2, 2002.
8. News article, Carbonless copy paper may pose risks. Fox 47 News, Reporter Victoria Dunkle, in Ingham County Community News, August 27, 2000, page 2.
9. News conference, attended by German television networks and the press, regarding the Neurotoxicity of Everyday Chemicals, Presskonferenz der Kassenarztlichen Vereinigung Nord-Wurttemberg, Stuttgart, Germany, June 10, 1999.
10. Expert panel discussion and dialogue. Healthier World for All: On preventing and living with MCS. In conjunction with New Mexico Gov. Gary Johnson's Proclamation of MCS Awareness Week, May 16, 1998.
11. Presentation, Pesticides and MCS. Educational meeting sponsored by the New Mexico Governor's Committee on Concerns of the Handicapped, June 24, 1996, Santa Fe.
12. Interview, German National Television - RTL. Program on pesticides and pyrethroids, October 24, 1994.
13. Panel presentation, Women, Health and the Environment Conference. Personal and occupational risks: How our daily lives are affected. October 15, 1994, Albuquerque.
14. Interview, Neurotoxic Chemicals and the Environment: Interview. Radio 1260 AM, Santa Fe, New Mexico. (1994).
15. Singer, R (1990) Comments in Healthy People 2000: Citizens Chart the Course Institute of Medicine, Chapter on Environmental Public Health, Page 148. National Academies Press, DC.
16. Singer, R. (1990). Neurotoxicity and Environmental Illness. The Human Ecologist, 48:15-17.
17. Interview, Radio WMCA, November 16, 1986. "In the Doctor's Office", New York.
Singer, R. (1978). The relationship between visual refractive error and interests, values, personality, academic performance, and reading. Washington State University, Washington.